# A Study of MORAb-009 in Patients With Solid Tumor

> **NCT01018784** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 17 (actual)

## Conditions studied

- Cancer
- Mesothelin-positive

## Interventions

- **DRUG:** MORAb-009

## Key facts

- **NCT ID:** NCT01018784
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-05
- **Final completion:** 2013-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01018784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01018784, "A Study of MORAb-009 in Patients With Solid Tumor". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01018784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*